Corcept Therapeutics (CORT) - News Mentions

Sign up to add (CORT) to your portfolio and access more historical data.

30%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 0 100%
Gilead Sciences
Gilead Sciences
GILD		 3 200%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 1 0%
Empowered Funds LLC Boosts Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT)
February 15
Corcept Therapeutics Incorporated (NASDAQ:CORT) Position Trimmed by Choreo LLC
February 15
HC Wainwright Issues Optimistic Estimate for CORT Earnings
February 14
Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Sold by Yousif Capital Management LLC
February 13
Equities Analysts Offer Predictions for CORT FY2029 Earnings
February 12
Corcept Therapeutics (NASDAQ:CORT) Receives “Buy” Rating from HC Wainwright
February 10
Corcept Therapeutics Offices – Redwood City
February 10
Zacks Research Has Optimistic Outlook of CORT Q3 Earnings
February 3
Q1 EPS Estimate for Corcept Therapeutics Raised by Analyst
February 1
Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Sold by Exchange Traded Concepts LLC
January 31
Corcept Therapeutics Incorporated (NASDAQ:CORT) Receives $65.25 Consensus PT from Analysts
January 31
Q1 EPS Estimate for Corcept Therapeutics Lifted by Analyst
January 30
Corcept Therapeutics price target raised by $52 at Canaccord, here's why
January 30
Corcept Therapeutics Incorporated (NASDAQ:CORT) Stock Position Raised by Nisa Investment Advisors LLC
January 29
Zacks Research Has Pessimistic Outlook of CORT Q3 Earnings
January 25
Kuehn Law Encourages Investors of Corcept Therapeutics Inc. to Contact Law Firm
January 23

How often is Corcept Therapeutics mentioned in the news?

Corcept Therapeutics was mentioned an estimated 3 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Corcept Therapeutics performing compared to its industry peers?

Corcept Therapeutics overperforms a majority of its industry peers when it comes to News Mentions, ranking in the 60th percentile.

Has there been an increase or decrease in news mentions of Corcept Therapeutics in the last month?

There has been no significant change in the number of news mentions for Corcept Therapeutics' compared to the last month.

Why is it important to track news mentions for Corcept Therapeutics?

By monitoring mentions in the news for Corcept Therapeutics, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Corcept Therapeutics, ultimately improving their investment strategies.

Sign up and get more insights on Corcept Therapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact